• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More or Call (407) 374-6986

Friday 11/16/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Hikma Pharmaceuticals

  • 7:33 AM

    May 09, 2017, INNV OTC Disclosure & News Service – Innovus Pharmaceuticals, Inc. (the “Company” or “Innovus Pharma”) (OTCQB Venture Market: INNV) and its partner West-Ward Pharmaceuticals International Limited (“WWPIL”), a wholly-owned subsidiary of Hikma Pharmaceuticals PLC (“Hikma”) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), today announced that WWPIL will provide the Company with the rights to launch its branded, fluticasone propionate nasal spray USP, 50 mcg per spray (FlutiCare™), under WWPIL’s FDA approved abbreviated new drug application (“ANDA”) No.

    Read more
  • 2:08 PM

    AUSTIN, TX, Apr 08, 2014 (Marketwired via COMTEX) — EPIC Corporation (PINKSHEETS: EPOR) (“EPIC”) and Ronald S. Tucker, EPIC’s president, announced, “EPIC’s Exchange Offer provides penny stock investors, those who are not day traders, with a rare opportunity. EPIC developed this sophisticated Exchange Offer to justify its management’s belief that its stock is undervalued by as much as 1165% at the current price level. It is also to provide investors, who purchase its shares at current or higher market prices,

    Read more
Public Wire Banner